Surveillance recommendations for patients with germline TP53 mutations, Curr Opin Oncol, vol.27, issue.4, pp.332-337, 2015. ,
Mutant p53 reactivation by small molecules makes its way to the clinic, FEBS Lett, vol.588, issue.16, pp.2622-2627, 2014. ,
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches, Nat Rev Mol Cell Biol, vol.10, issue.11, pp.741-754, 2009. ,
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel, Blood, vol.129, issue.4, pp.424-447, 2017. ,
Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors, Proc Natl Acad Sci U S A, vol.109, issue.24, pp.9551-9556, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01188067
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer, EBioMedicine, vol.10, pp.117-123, 2016. ,
Coming of age: ten years of next-generation sequencing technologies, Nat Rev Genet, vol.17, issue.6, pp.333-351, 2016. ,
Splice mutations in the p53 gene: case report and review of the literature, Hum Mutat, vol.21, issue.1, pp.101-102, 2003. ,
p53 Isoforms: Key Regulators of the Cell Fate Decision, Cold Spring Harb Perspect Med, vol.6, issue.8, 2016. ,
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis, Proc Natl Acad Sci U S A, vol.100, issue.14, pp.8424-8429, 2003. ,
Drugging the p53 pathway: understanding the route to clinical efficacy, Nat Rev Drug Discov, vol.13, issue.3, pp.217-236, 2014. ,
The isoforms of the p53 protein, Cold Spring Harb Perspect Biol, vol.2, issue.3, p.927, 2010. ,
Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation, Genome Med, vol.9, issue.1, p.13, 2017. ,
Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues, Proc Natl Acad Sci, vol.113, issue.21, pp.6005-6010, 2016. ,
TP53 mutations in human cancer: database reassessment and prospects for the next decade, Hum Mutat, vol.35, issue.6, pp.672-688, 2014. ,
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice, Cancer Res, vol.6, pp.1250-1260, 2017. ,
dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs, Hum Mutat, vol.37, issue.3, pp.235-241, 2016. ,
The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis, PLoS One, vol.12, issue.9, 2017. ,
,
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation, Leukemia, 2018. ,
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations, Nature, vol.545, issue.7653, pp.229-233, 2017. ,
,
Direct detection of early-stage cancers using circulating tumor DNA, Sci Transl Med, issue.403, p.9, 2017. ,
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia, Leukemia, vol.26, issue.7, pp.1458-1461, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02318055
,
,
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, issue.5, pp.405-424, 2015. ,
Locus-specific databases in cancer: what future in a post-genomic era? The TP53 LSDB paradigm, Hum Mutat, vol.35, issue.6, pp.643-653, 2014. ,
Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era, Hum Mutat, vol.35, issue.6, pp.766-778, 2014. ,
Synonymous Somatic Variants in Human Cancer Are Not Infamous: A Plea for Full Disclosure in Databases and Publications, Hum Mutat, vol.38, issue.4, pp.339-342, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02318074
TP53: an oncogene in disguise, Cell Death Differ, vol.22, issue.8, pp.1239-1249, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01188060
Describing structural changes by extending HGVS sequence variation nomenclature, Hum Mutat, vol.32, issue.5, pp.507-511, 2011. ,
Potential Pitfall of Pluripotent Stem Cells, N Engl J Med, vol.377, issue.5, pp.490-491, 2017. ,
A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier, Br J Cancer, vol.78, issue.8, pp.1081-1083, 1998. ,
Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker, Hum Mutat, vol.29, issue.1, pp.6-13, 2008. ,
A variant by any name: quantifying annotation discordance across tools and clinical databases, Genome Med, vol.9, issue.1, p.7, 2017. ,